Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Margin of Safety % (DCF FCF Based): N/A (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02291 Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
76 GF Score
Price HK$12.18
GF Value HK$44.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lepu Scientech Medical Technology (Shanghai) Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Lepu Scientech Medical Technology (Shanghai) Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HKSE:02291 vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lepu Scientech Medical Technology (Shanghai) Co Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Margin of Safety % (DCF FCF Based) falls into.


HKSE:02291
76GF Score
Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?

Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued. The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29. GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.

Key valuation signals for HKSE:02291:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lepu Scientech Medical Technology (Shanghai) Co Business Description

Address No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score

Get the complete analysis for HKSE:02291

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.18
Price
HK$44.29
GF Value